ClinicalTrials.Veeva

Menu

Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients

The Ohio State University logo

The Ohio State University

Status

Completed

Conditions

Breast Cancer
Prostate Cancer

Treatments

Other: questionnaire administration

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT01823549
OSU-0240

Details and patient eligibility

About

This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.

Enrollment

109 patients

Sex

All

Ages

21 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion/Exclusions

  • Men that have histologically proven carcinoma of the prostate and have chosen some form of radiation therapy as their primary therapy for prostate cancer.
  • Women who are undergoing external beam radiation therapy to the breast as primary or adjuvant therapy are eligible.
  • All participants must be able to read and write.
  • Subjects with dementia and mental retardation that complicates completing the questionnaires will not be enrolled.
  • Subjects with known metastatic disease will be excluded.
  • There are no age restrictions for this study.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems